PATENT CLAIM ANALYSIS

Application Number: 15894546
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["435", "006100"]

Abstract:
The invention relates to improved methods, devices, and kits for identifying and implementing an appropriate treatment regimen for subjects suffering from hypertension.

Claim (Index 86):
A method according to  claim 67  wherein an ACE inhibitor is enalapril, lisinopril, captopril alacipril, benazapril, cilazapril, delapril, fosinopril, perindopril, quinapril, ramipril, moveltipril, spirapril, ceronapril, imidapril, temocapril, trandolopril, utilbapril, zofenopril, CV5975, EMD 56855, libenzapril, zalicipril, HOE065, MDL 27088, AB47, DU 1777, MDL 27467A, Equaten\u2122, Prentyl\u2122, Synecor\u2122 or Y23785.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 88.0
- Lexical Diversity: 1.13636
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15314641', '15037030', '10077870', '15813469', '13799682']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5207943914869578
- 35 USC 102 Novelty (BERT): 0.6618162162964009
- Combined Prediction Score: 0.5348965739679021
- Mean Citation Score: 302.041664
- Max Citation Score: 652.6511
- Similarity Product: 607.1844627042352

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test